[ad_1]
Medical system firm AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a rise in adjusted revenue for the fourth quarter of 2023, aided by a 5% development in revenues. The corporate additionally supplied steering for fiscal 2024.
Earnings, excluding particular gadgets, edged as much as $0.02 per share within the Could quarter from $0.01 per share in the identical interval of 2022. On an unadjusted foundation, it was a web lack of $21.5 million or $0.54 per share, in comparison with a lack of $6.27 million or $0.16 per share within the prior-year quarter.
Fourth-quarter revenues elevated 5% year-over-year to $91.1 million. The corporate expects fiscal 2024 revenues to be within the vary of $328 million to $333 million.
Commenting on the outcomes, AngioDynamics’ CEO Jim Clemmer mentioned, “Trying forward, we’ll proceed to hunt alternatives to additional focus the portfolio in an effort to drive development and margin growth.”
Prior Efficiency
[ad_2]
Source link
